UnknownPhase 2NCT03882346

Study to Evaluate Safety and Efficacy of LifeLiver in Acute or Acute-on-Chronic Liver Failure Patients

Studying Acute liver failure

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
HLB Cell Co., Ltd.
Principal Investigator
Dong Hyun Sinn, MD, Ph.D
Samsung Medical Center
Intervention
LifeLiver(combination_product)
Enrollment
40 enrolled
Eligibility
18-60 years · All sexes
Timeline
20192022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03882346 on ClinicalTrials.gov

Other trials for Acute liver failure

Additional recruiting or active studies for the same condition.

See all trials for Acute liver failure

← Back to all trials